Single-institutional observational surveillance of nivolumab for previously treated with non-small cell lung cancer

Single-institutional observational surveillance of nivolumab for previously treated with non-small cell lung cancer - observational study of nivolumab

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021694

Enrollment

100

Registered

2016-04-01

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients treated with nivolumab for previously treated with NSCLC from 2016

Exclusion criteria

Exclusion criteria: inadequate patients for nivolumab treatment

Design outcomes

Primary

Measure	Time frame
response rate	—

Secondary

Measure	Time frame
progression-free survival; overall survival; safety; predictive factor of prognosis and safety	—

Countries

Japan

Contacts

Public ContactYusuke Okuma

Tokyo Metropolitan Komagome Hospital Department of Thoracic Oncology

y-okuma@cick.jp03-3823-2101

Outcome results